Thermo Fisher Scientific Wins Innovation Award in Informatics for Second Consecutive Year
News Jul 16, 2009
Thermo Fisher Scientific Inc. has announced that it has been named the winner of the Microsoft Corporation 2009 Pharmaceutical and Life Sciences Innovation Award in the Discovery and Product Innovation category, for the second consecutive year.
The award honors best-in-class companies for their use of Microsoft-based solutions. Microsoft selected Norway-based Hunt Research Centre and Biobank in recognition of its use of Thermo Scientific Nautilus to better manage and analyze the large amounts of real-time medical data and provide valuable insight into disease status and progression.
Thermo Scientific Nautilus LIMS provided HUNT with a comprehensive biobanking solution to gather, store, manage, track and retrieve large amounts of data securely, and yield real-time, dependable analysis and reports.
The Award, announced at the Drug Information Association’s (DIA) 45th Annual Meeting in San Diego, was presented to Thermo Fisher Scientific and Hunt Research Centre and Biobank to acknowledge the technology solutions used for one of the largest population-based health study ever performed.
Hunt Research Centre and Biobank implemented Thermo Scientific Nautilus LIMS to automate their process from the clinic to the laboratory in order to accommodate for the vast scope and progressively increasing study complexity. Building on the Microsoft technology, the Thermo Fisher and Hunt application is used on one of the largest health studies ever performed.
Three studies spanning 25 years have been run on an integrated family and personal database of approximately 100,000 people from Norway. The studies support epidemiological, clinical and preventative medical research and offer valuable insight into disease status and progression. Hunt paired Thermo Scientific Nautilus LIMS with Microsoft technology which included InfoPath and SQL Server to increase throughput and automation.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
New Algorithms Help Extract 3-D Biological Structure from Limited DataNews
CAMERA researchers capitalize on their Multi-Tiered Iterative Phasing approach to determine molecular structure of proteins and viruses from X-ray free electron laser data.READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018
EMBL Course: Bioinformatics Resources for Protein Biology
Mar 06 - Mar 08, 2018
EMBL Course: Introduction to Omics Data Integration
Feb 19 - Feb 23, 2018